XML 63 R23.htm IDEA: XBRL DOCUMENT v3.2.0.727
Composition of Certain Financial Statement Captions (Tables)
6 Months Ended
Jun. 30, 2015
Compositions of Certain Financial Statement Captions [Abstract]  
Composition of certain financial statement captions
(In thousands)
June 30,
2015
 
December 31,
2014
Accounts receivable, net
 
 
 
Accounts receivable
$
29,045

 
$
21,875

Less: allowance for doubtful accounts
(2,065
)
 
(1,906
)
 
$
26,980

 
$
19,969

Inventories, net
 
 
 
Finished products
$
13,830

 
$
12,116

Work in-process
1,619

 
1,011

Raw materials
5,782

 
4,116

Less: inventory reserve
(712
)
 
(639
)
 
$
20,519

 
$
16,604

Prepaid expenses and other current assets
 
 
 
Prepaid supplies
$
1,441

 
$
1,123

Prepaid insurance
613

 
968

Other receivables
1,107

 
669

Taxes recoverable
3,074

 
2,417

Other
3,388

 
4,212

 
$
9,623

 
$
9,389

Intangible assets, net:
 
 
 
Technologies
$
52,287

 
$
52,508

Customer relationships
55,750

 
22,108

Product registrations
8,088

 
8,763

Trade names
3,411

 
3,483

Covenants not to compete
8,620

 
8,639

Other
4,889

 
1,079

Less:  accumulated amortization
(38,798
)
 
(33,931
)
 
$
94,247

 
$
62,649

Accrued expenses:
 
 
 
Taxes payable
$
2,592

 
$
77

Deferred revenue
75,159

 
4,185

Clinical trials
8,534

 
8,643

Professional fees
1,724

 
1,860

Employee benefits
5,456

 
4,127

Contingent consideration
41,146

 
27,352

Other
15,232

 
14,668

 
$
149,843

 
$
60,912

 
 
 
 
(In thousands)
June 30,
2015
 
December 31,
2014
Other long-term liabilities:
 
 
 
Contingent consideration – OPKO Renal
$
19,183

 
$
36,529

Contingent consideration – OPKO Health Europe
225

 
254

Contingent consideration – OPKO Diagnostics
13,342

 
6,992

Contingent consideration – CURNA
433

 
440

Mortgages and other debts payable
2,148

 
2,434

Deferred tax liabilities
172,458

 
167,153

Deferred revenue
197,279

 
2,526

Other
3,753

 
1,030

 
$
408,821

 
$
217,358

Schedule of goodwill
The following table reflects the changes in Goodwill during the six months ended June 30, 2015.
 
2015
(In thousands)
Balance at January 1st
 
Acquisitions
 
Foreign exchange
 
Balance at June 30th
Pharmaceuticals
 
 
 
 
 
 
 
CURNA
$
4,827

 
$

 
$

 
$
4,827

OPKO Mexico
100

 

 
(5
)
 
95

OPKO Chile
5,283

 

 
(243
)
 
5,040

OPKO Health Europe
8,013

 

 
(699
)
 
7,314

FineTech
11,698

 

 

 
11,698

SciVac
1,553

 

 
49

 
1,602

OPKO Renal
2,069

 

 

 
2,069

OPKO Biologics
139,784

 

 

 
139,784

EirGen Pharma Ltd

 
66,823

 
(610
)
 
66,213

Diagnostics
 
 
 
 
 
 
 
OPKO Diagnostics

17,977

 

 

 
17,977

OPKO Lab
32,988

 

 

 
32,988

 
$
224,292

 
$
66,823

 
$
(1,508
)
 
$
289,607